These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35116339)

  • 1. LncRNA NEAT1-miR-101-3p/miR-335-5p/miR-374a-3p/miR-628-5p-TRIM6 axis identified as the prognostic biomarker for lung adenocarcinoma via bioinformatics and meta-analysis.
    Ding DX; Li Q; Shi K; Li H; Guo Q; Zhang YQ
    Transl Cancer Res; 2021 Nov; 10(11):4870-4883. PubMed ID: 35116339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
    Li J; Gu X; Gao C; Zhang J
    Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-490-3p Sponged by lncRNA NEAT1 Can Attenuate Lung Adenocarcinoma Progression by Suppressing the RhoA/ROCK Signaling Pathway.
    Zhao L; Ren C; Fang Y; Li P; Zhang H; Zuo L; Zhang J; Zhao J
    Ann Clin Lab Sci; 2023 Jan; 53(1):42-51. PubMed ID: 36889766
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-195-3p is a Novel Prognostic Biomarker Associated with Immune Infiltrates of Lung Adenocarcinoma.
    Lao Y; Li T; Xie X; Chen K; Li M; Huang L
    Int J Gen Med; 2022; 15():191-203. PubMed ID: 35023957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, Clinical Significance, Immune Infiltration, and Regulation Network of miR-3940-5p in Lung Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation.
    Lin Z; Huang W; Xie Z; Yi Y; Li Z
    Int J Gen Med; 2022; 15():6451-6464. PubMed ID: 35966511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma.
    Shi K; Li QY; Zhang YQ; Huang H; Ding DX; Luo WM; Zhang J; Guo Q
    Aging (Albany NY); 2023 Oct; 15(20):11067-11091. PubMed ID: 37899135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression.
    Liu Z; Yang S; Zhou S; Dong S; Du J
    Cancer Manag Res; 2021; 13():8367-8376. PubMed ID: 34764698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of non-coding RNA-mediated high expression of IQGAP3 in poor prognosis of lung adenocarcinoma.
    Su Z; Wang Y; Cao J; Ma J; Wang G; Ren H; Zhang Y; Sheng K; Zhu X; Wang Y
    J Gene Med; 2024 Jan; 26(1):e3664. PubMed ID: 38282143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-21-5p is a Biomarker for Predicting Prognosis of Lung Adenocarcinoma by Regulating PIK3R1 Expression.
    Du J; Qian J; Zheng B; Xu G; Chen H; Chen C
    Int J Gen Med; 2021; 14():8873-8880. PubMed ID: 34858053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5.
    Meng X; Sun Y; Liu S; Mu Y
    Oncol Lett; 2021 Apr; 21(4):282. PubMed ID: 33732358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1.
    Duan L; Wang J; Zhang D; Yuan Y; Tang L; Zhou Y; Jiang X
    Front Oncol; 2022; 12():862564. PubMed ID: 35600383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways.
    Wang SS; Fang YY; Huang JC; Liang YY; Guo YN; Pan LJ; Chen G
    Oncol Lett; 2019 Sep; 18(3):2939-2954. PubMed ID: 31402959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
    Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
    Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence.
    Zhen S; Jia Y; Zhao Y; Wang J; Zheng B; Liu T; Duan Y; Lv W; Wang J; Xu F; Liu Y; Zhang Y; Liu L
    Cell Death Discov; 2024 Mar; 10(1):131. PubMed ID: 38472205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis.
    Misono S; Seki N; Mizuno K; Yamada Y; Uchida A; Arai T; Kumamoto T; Sanada H; Suetsugu T; Inoue H
    J Hum Genet; 2018 Oct; 63(10):1015-1028. PubMed ID: 30082847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-106b-5p inhibits growth and progression of lung adenocarcinoma cells by downregulating IGSF10.
    Ling B; Liao X; Tang Q; Ye G; Bin X; Wang J; Pang Y; Qi G
    Aging (Albany NY); 2021 Jul; 13(14):18740-18756. PubMed ID: 34351868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma.
    Ma L; Zhang L; Li L; Zhao L
    Open Med (Wars); 2023; 18(1):20230686. PubMed ID: 37069939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.